Baby born prematurely at 29 weeks on examination at 42 weeks with ROP both eyes shows stage 2 zone I “plus’ disease, how will you manage the patient?
ROP is a vasoproliferative disorder affecting the retinas of preterm infants. The stages range from 1 to 5, with higher stages indicating more severe disease. Zone I is the most posterior part of the retina, and "plus disease" refers to the dilation and tortuosity of the retinal vessels, which is a sign of aggressive ROP.
Stage 2 ROP in zone I with plus disease is considered a threshold for treatment. The management options typically include laser photocoagulation or anti-VEGF agents. Laser therapy is the standard of care for threshold ROP, as it helps prevent progression to retinal detachment. Anti-VEGF drugs like bevacizumab might be used in certain cases, but laser is preferred for zone I plus disease.
Looking at the options, the correct answer would be laser photocoagulation. The other options might include things like observation (which is incorrect for threshold disease), anti-VEGF (which is not first-line here), or maybe some other treatments. The key is knowing the threshold for intervention in ROP guidelines, such as those from the American Academy of Pediatrics or the International Classification of ROP.
I need to make sure the explanation covers the staging, the significance of plus disease in zone I, and the standard treatment. Also, explain why the other options are incorrect. The clinical pearl here is the threshold for treatment in ROP, which is critical for exams.
**Core Concept** Retinopathy of Prematurity (ROP) is a vasoproliferative disorder in preterm infants, managed based on staging, zones, and presence of "plus disease." Zone I stage 2 with plus disease is a **threshold for treatment** to prevent retinal detachment.
**Why the Correct Answer is Right**
Laser photocoagulation is the **first-line treatment** for threshold ROP (stage 2 zone I with plus disease). It destroys avascular retina, reducing vascular endothelial growth factor (VEGF) production and halting neovascularization. This prevents progression to stage 4/5 ROP, which causes retinal detachment. The procedure targets the avascular peripheral retina, sparing central vision.
**Why Each Wrong Option is Incorrect**
**Option A:** Observation is incorrect—threshold ROP requires immediate intervention to prevent blindness.
**Option B:** Anti-VEGF agents (e.g., bevacizumab) are **not first-line** for zone I disease. They may be used in selected cases but lack long-term efficacy in zone I due to incomplete regression.
**Option C:** Scleral buckling is for retinal detachment (stage 4/5), not threshold ROP.
**Option D:** Cryotherapy is outdated; laser is preferred due to better visual outcomes and fewer complications.
**Clinical Pearl**
**Threshold ROP** = **Stage 2 zone I with plus disease** OR **Stage 3 without plus in zone I**. Immediate referral to a pediatric ophthalmologist for **laser photocoagulation** is mandatory. Remember: **Plus disease = aggressive ROP** requiring urgent treatment.
**Correct